primaquine has been researched along with atovaquone in 51 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 7 (13.73) | 18.2507 |
2000's | 15 (29.41) | 29.6817 |
2010's | 24 (47.06) | 24.3611 |
2020's | 5 (9.80) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Benoit-Vical, F; Berry, A; Cazelles, J; Dechy-Cabaret, O; Deymier, C; Lelièvre, J; Loup, C; Magnaval, JF; Meunier, B; Robert, A | 1 |
Danis, M; Derouin, F; Farhati, K; Franetich, JF; Galvez, J; Garcia-Domenech, R; Hannoun, L; Mahmoudi, N; Mazier, D; Sauerwein, R | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Lopes, F; Moreira, R; Mota, MM; Prudêncio, M; Rodrigues, T | 1 |
Bronze, MR; da Cruz, FP; Gamo, FJ; Gonçalves, D; Gut, J; Lafuente-Monasterio, MJ; Lopes, F; Moreira, R; Mota, MM; Prudêncio, M; Ressurreição, AS; Rodrigues, T; Rosenthal, PJ; Schneider, G; Sitoe, AR | 1 |
Fidock, DA; Flannery, EL; Winzeler, EA | 1 |
Albuquerque, IS; Bronze, MR; Gonçalves, LM; Guedes, RC; Gut, J; Lopes, F; Meireles, P; Moreira, R; O'Neill, PM; Oliveira, R; Pires, E; Prudêncio, M; Rosenthal, PJ | 1 |
Iyer, PS; Kannan, M; Khan, FR; Raichurkar, AV | 1 |
Azas, N; Basmaciyan, L; Cohen, A; Crozet, MD; Dallemagne, P; Deharo, E; Dumètre, A; Hutter, S; Laget, M; Lancelot, JC; Lesnard, A; Lorthiois, A; Mazier, D; Paloque, L; Rathelot, P; Rault, S; Sibley, CH; Suzanne, P; Valentin, A; Vanelle, P; Verhaeghe, P | 1 |
Chibale, K; de Kock, C; Kaur, H; Machado, M; Prudêncio, M; Singh, K; Smith, P | 1 |
Albuquerque, IS; Burojević, J; D'Alessandro, S; Djurković-Djaković, O; Konstantinović, J; Machado, M; Pecic, S; Prudêncio, M; Sciotti, RJ; Šolaja, BA; Srbljanović, J; Štajner, T; Taramelli, D; Terzić, N; Tot, M; Verbić, T; Zlatović, M | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Barnard, L; Birkholtz, LM; Botha, M; Brunschwig, C; Burrows, JN; Chibale, K; Churchyard, A; Coetzer, TL; Denti, P; Egan, TJ; Laing, L; Lauterbach, S; Machado, M; Ndubi, F; Njogu, PM; Njoroge, M; Nondaba, S; Okombo, J; Prudêncio, M; Reader, J; Singh, K; Wiesner, L; Wilkinson, C; Wittlin, S; Yeates, C | 1 |
Blake, LD; Burrows, JN; Casandra, D; Kyle, DE; LaCrue, AN; Lichorowic, CL; Maignan, JR; Manetsch, R; Mashkouri, S; Monastyrskyi, A; Mutka, TS; Neelarapu, R; Willis, PA | 1 |
Bane, CE; Black, C; Butler, K; Caridha, D; Cooper, RA; Dodean, RA; Gaona, H; Gaynor-Ohnstad, L; Huezo, SJ; Kancharla, P; Kelly, JX; Kreishman-Deitrick, M; Leed, SE; Li, Q; Li, Y; Lin, H; Luong, TL; Marcsisin, S; Melendez, V; Nolan, C; Olmeda, R; Potter, B; Pou, S; Rasmussen, SA; Read, L; Riscoe, MK; Roncal, N; Sciotti, RJ; Smilkstein, MJ; Sousa, J; Stephens, MT; Tan, JC; Vesely, B; Vuong, C; Winter, RW; Xie, L; Zeng, Q; Zhang, J; Zhang, P | 1 |
Cheong, SL; Ng, CH; Tibon, NS | 1 |
Fontinha, D; Francisco, D; Mendes, AM; Prudêncio, M; Singh, K; Singh, L | 1 |
Bane, CE; Bayles, BR; Black, C; Butler, K; Caridha, D; Ceja, FG; Cooper, RA; Dodean, RA; Gaona, H; Gaynor-Ohnstad, L; Kancharla, P; Kelly, JX; Kreishman-Deitrick, M; Leed, SE; Li, Q; Li, Y; Lin, H; Luong, TL; Marcsisin, S; Melendez, V; Mu, J; Nolan, C; Olmeda, R; Potter, B; Pou, S; Pybus, B; Rasmussen, SA; Read, L; Reynolds, KA; Riscoe, MK; Roncal, N; Rosenthal, PJ; Sciotti, RJ; Smilkstein, MJ; Sousa, J; Tumwebaze, PK; Vesely, B; Vuong, C; Xie, L; Zeng, Q; Zhang, J; Zhang, P | 1 |
Masur, H | 1 |
Lizasoain, M; Lumbreras, C; Pastor, C | 1 |
Bogner, JR; Goebel, FD | 1 |
Korraa, H; Saadeh, C | 1 |
Deresinski, SC | 1 |
Davis, TM | 1 |
Kain, KC; Keystone, JS; Shanks, GD | 1 |
Baird, JK; Bangs, MJ; Barcus, MJ; Basri, H; Fryauff, DJ; Gramzinski, R; Hoffman, SL; Jones, TR; Kusumaningsih, M; Lacy, MD; Ling, J; Maguire, JD; Sismadi, P; Wiady, I | 1 |
Jong, EC; Nothdurft, HD | 1 |
Barrett, PH; Davis, TM; Ilett, KF; Syed, DA | 1 |
Cook, T; Gibson, N; Gray, G; Kenny, G; McCarthy, AE; Paul, MA | 1 |
Chambers, JA | 1 |
Binh, TQ; de Vries, PJ; Giao, PT; Hung, le Q; Kager, PA; Nam, NV | 1 |
Bellamy, R | 3 |
Croft, AM; Jacquerioz, FA | 2 |
Bozzo, P; Einarson, A; Irvine, MH | 1 |
Arguin, PM; Magill, AJ; Steinhardt, LC | 1 |
Ariey, F; Bjorge, S; Chea, N; Christophel, EM; Duong, S; Habib, N; Hoyer, S; Kheng, S; Khim, N; Kim, S; Mellor, S; Menard, D; Newman, RD; Nguon, S; Ros, S; Sophal, U; Sum, S; Thompson, MM; Thomson, A; Top, S; Witkowski, B; Yeang, C; Yeung, S; Yok, S | 1 |
Beenhakker, N; Iwanaga, S; Janse, CJ; Klooster, EJ; Kocken, CH; Koopman, G; Sauerwein, R; Thomas, AW; van Amsterdam, SM; van den Berg, A; van Gemert, GJ; Voorberg-van der Wel, A; Zeeman, AM | 1 |
Berman, J; DiTusa, C; Gettayacamin, M; Im-erbsin, R; Kozar, MP; Ohrt, C; Pybus, B; Sousa, J; Tungtaeng, A | 1 |
David, K; Møller, CH | 1 |
Bhardwaj, J; Goyal, M; Prakash, K; Puri, SK; Siddiqui, AJ; Soni, A; Tiwari, V | 1 |
Maayan, N; Pace, C; Saunders, R; Sinclair, D; Tickell-Painter, M | 1 |
Arsuaga, M; Dinkessa, AW; González, LM; Gray, J; Montero, E; Padial, ES; Puente, S; Sevilla, E; Trigo, E | 1 |
Baier, M; Eisermann, P; Hagel, S; Reuken, PA; Rödel, J; Stallmach, A | 1 |
Brett-Major, D; Fraser, J; Hickey, PW; Mitra, I; Riddle, MS; Tribble, DR | 1 |
Abichabki, NLM; Abreu-Filho, PG; Baroni, L; Brochi, JCV; de Luca, G; Pereira, LM; Yatsuda, AP | 1 |
19 review(s) available for primaquine and atovaquone
Article | Year |
---|---|
Targeting the liver stage of malaria parasites: a yet unmet goal.
Topics: Animals; Antimalarials; Humans; Life Cycle Stages; Liver; Malaria; Plasmodium; Structure-Activity Relationship | 2012 |
Using genetic methods to define the targets of compounds with antimalarial activity.
Topics: Animals; Anopheles; Antimalarials; Drug Resistance; Genetic Association Studies; Genome, Protozoan; Humans; Malaria, Falciparum; Molecular Targeted Therapy; Plasmodium falciparum | 2013 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Current progress in antimalarial pharmacotherapy and multi-target drug discovery.
Topics: Animals; Antimalarials; Artemisinins; Drug Discovery; Drug Resistance; Humans; Malaria; Molecular Structure; Paclitaxel; Quinolines | 2020 |
Prophylaxis and therapy for Pneumocystis pneumonia--where are we?
Topics: Adrenal Cortex Hormones; AIDS-Related Opportunistic Infections; Antifungal Agents; Atovaquone; Clindamycin; Clinical Trials as Topic; Drug Tolerance; Humans; Naphthoquinones; Pneumonia, Pneumocystis; Primaquine; Trimethoprim, Sulfamethoxazole Drug Combination | 1992 |
[Current alternatives in the treatment of Pneumocystis carinii pneumonia in patients with AIDS].
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Atovaquone; Clindamycin; Dapsone; Eflornithine; Humans; Naphthoquinones; Pneumonia, Pneumocystis; Primaquine; Trimethoprim; Trimetrexate | 1994 |
[Therapy and prevention of pneumocystis carinii pneumonia].
Topics: AIDS-Related Opportunistic Infections; Animals; Antifungal Agents; Atovaquone; Clindamycin; Clinical Trials as Topic; Dapsone; Humans; Naphthoquinones; Pentamidine; Pneumonia, Pneumocystis; Primaquine; Trimethoprim, Sulfamethoxazole Drug Combination | 1995 |
Options in the management of pneumonia caused by Pneumocystis carinii in patients with acquired immune deficiency syndrome and intolerance to trimethoprim/sulfamethoxazole.
Topics: Adrenal Cortex Hormones; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Antifungal Agents; Atovaquone; Clindamycin; Dapsone; Drug Combinations; Drug Hypersensitivity; Drug Resistance, Microbial; Humans; Leucovorin; Naphthoquinones; Pentamidine; Pneumonia, Pneumocystis; Primaquine; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Trimetrexate | 1996 |
Treatment of Pneumocystis carinii pneumonia in adults with AIDS.
Topics: Administration, Oral; Adult; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Antifungal Agents; Atovaquone; Clindamycin; Dapsone; Humans; Infusions, Intravenous; Naphthoquinones; Pentamidine; Pneumonia, Pneumocystis; Primaquine; Trimethoprim, Sulfamethoxazole Drug Combination; Trimetrexate | 1997 |
Malaria chemoprophylaxis in the age of drug resistance. I. Currently recommended drug regimens.
Topics: Animals; Antimalarials; Atovaquone; Azithromycin; Chloroquine; Drug Resistance; Health Planning Guidelines; Humans; Malaria, Falciparum; Mefloquine; Naphthoquinones; Plasmodium falciparum; Primaquine; Proguanil | 2001 |
Current drugs for antimalarial chemoprophylaxis: a review of efficacy and safety.
Topics: Antimalarials; Atovaquone; Chloroquine; Doxycycline; Humans; Malaria; Mefloquine; Naphthoquinones; Primaquine; Proguanil | 2001 |
Military aviators, special operations forces, and causal malaria prophylaxis.
Topics: Aminoquinolines; Antimalarials; Atovaquone; Aviation; Chloroquine; Doxycycline; Drug Combinations; Humans; Malaria; Mefloquine; Military Personnel; Naphthoquinones; Primaquine; Proguanil; United States | 2003 |
Pneumocystis carinii pneumonia treatment in people infected with HIV.
Topics: Antifungal Agents; Atovaquone; Clindamycin; Dapsone; Drug Therapy, Combination; HIV Infections; Humans; Naphthoquinones; Pentamidine; Pneumonia, Pneumocystis; Primaquine; Trimethoprim, Sulfamethoxazole Drug Combination | 2004 |
Pneumocystis pneumonia in people with HIV.
Topics: Atovaquone; Clindamycin; Corticosterone; Dapsone; Drug Therapy, Combination; HIV Infections; Humans; Naphthoquinones; Pentamidine; Pneumonia, Pneumocystis; Primaquine; Trimethoprim, Sulfamethoxazole Drug Combination | 2005 |
Pneumocystis pneumonia in people with HIV.
Topics: Anti-Infective Agents; Antiprotozoal Agents; Atovaquone; Clindamycin; Dapsone; Drug Therapy, Combination; HIV Infections; Humans; Pentamidine; Pneumonia, Pneumocystis; Primaquine; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 2006 |
Drugs for preventing malaria in travellers.
Topics: Adult; Antimalarials; Atovaquone; Child; Chloroquine; Doxycycline; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Humans; Malaria, Falciparum; Mefloquine; Primaquine; Proguanil; Randomized Controlled Trials as Topic; Travel | 2009 |
Review: Malaria chemoprophylaxis for travelers to Latin America.
Topics: Antimalarials; Atovaquone; Drug Combinations; Drug Therapy, Combination; Humans; Latin America; Malaria; Malaria, Vivax; Plasmodium vivax; Primaquine; Proguanil; Travel | 2011 |
WITHDRAWN: Drugs for preventing malaria in travellers.
Topics: Adult; Antimalarials; Atovaquone; Child; Chloroquine; Doxycycline; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Humans; Malaria, Falciparum; Mefloquine; Primaquine; Proguanil; Randomized Controlled Trials as Topic; Travel | 2015 |
Mefloquine for preventing malaria during travel to endemic areas.
Topics: Adult; Antimalarials; Atovaquone; Child; Chloroquine; Doxycycline; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Humans; Malaria, Falciparum; Mefloquine; Primaquine; Proguanil; Randomized Controlled Trials as Topic; Travel-Related Illness | 2017 |
3 trial(s) available for primaquine and atovaquone
Article | Year |
---|---|
Randomized, parallel placebo-controlled trial of primaquine for malaria prophylaxis in Papua, Indonesia.
Topics: Adolescent; Adult; Animals; Antimalarials; Atovaquone; Chemoprevention; Child; Drug Combinations; Female; Humans; Indonesia; Malaria, Falciparum; Male; Methemoglobinemia; Middle Aged; Naphthoquinones; Patient Compliance; Plasmodium falciparum; Primaquine; Proguanil; Treatment Outcome | 2001 |
The impact of Malarone and primaquine on psychomotor performance.
Topics: Adult; Affect; Antimalarials; Atovaquone; Colic; Cross-Over Studies; Diarrhea; Double-Blind Method; Drug Combinations; Fatigue; Female; Headache; Humans; Male; Middle Aged; Naphthoquinones; Nausea; Patient Compliance; Primaquine; Proguanil; Psychomotor Performance | 2003 |
CV8, a new combination of dihydroartemisinin, piperaquine, trimethoprim and primaquine, compared with atovaquone-proguanil against falciparum malaria in Vietnam.
Topics: Adolescent; Adult; Aged; Animals; Antimalarials; Artemisinins; Atovaquone; Drug Combinations; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Middle Aged; Naphthoquinones; Parasitemia; Plasmodium falciparum; Primaquine; Proguanil; Quinolines; Sesquiterpenes; Treatment Outcome; Trimethoprim; Vietnam | 2004 |
29 other study(ies) available for primaquine and atovaquone
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Trioxaquines are new antimalarial agents active on all erythrocytic forms, including gametocytes.
Topics: Aminoquinolines; Animals; Antimalarials; Erythrocytes; Mice; Plasmodium falciparum | 2007 |
New active drugs against liver stages of Plasmodium predicted by molecular topology.
Topics: Animals; Antimalarials; Hepatocytes; Humans; Liver; Mice; Models, Biological; Parasitic Sensitivity Tests; Plasmodium yoelii; Structure-Activity Relationship | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Quinolin-4(1H)-imines are potent antiplasmodial drugs targeting the liver stage of malaria.
Topics: Antimalarials; Cell Line, Tumor; Humans; Imines; Liver; Malaria; Parasitic Sensitivity Tests; Plasmodium berghei; Plasmodium falciparum; Quinolines; Structure-Activity Relationship | 2013 |
Tetraoxane-pyrimidine nitrile hybrids as dual stage antimalarials.
Topics: Animals; Antimalarials; Cell Line; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Humans; Malaria; Mice, Inbred C57BL; Molecular Docking Simulation; Nitriles; Oxidative Stress; Peptidomimetics; Plasmodium berghei; Plasmodium falciparum; Pyrimidines; Structure-Activity Relationship; Tetraoxanes | 2014 |
Synthesis and in vitro evaluation of novel 8-aminoquinoline-pyrazolopyrimidine hybrids as potent antimalarial agents.
Topics: Aminoquinolines; Antimalarials; Humans; Malaria, Falciparum; Molecular Docking Simulation; Parasitic Sensitivity Tests; Plasmodium falciparum; Pyrazoles; Pyrimidines; Structure-Activity Relationship | 2015 |
Discovery of new thienopyrimidinone derivatives displaying antimalarial properties toward both erythrocytic and hepatic stages of Plasmodium.
Topics: Animals; Antimalarials; Cell Proliferation; CHO Cells; Cricetinae; Cricetulus; Drug Discovery; Erythrocytes; Hep G2 Cells; Humans; Liver; Malaria; Male; Mice; Parasitemia; Plasmodium falciparum; Pyrimidines; Structure-Activity Relationship; Trophozoites | 2015 |
Primaquine-pyrimidine hybrids: synthesis and dual-stage antiplasmodial activity.
Topics: Animals; Antimalarials; Cell Line; Dose-Response Relationship, Drug; Humans; Liver; Mice; Mice, Inbred C57BL; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium berghei; Primaquine; Pyrimidines; Structure-Activity Relationship | 2015 |
Reinvestigating Old Pharmacophores: Are 4-Aminoquinolines and Tetraoxanes Potential Two-Stage Antimalarials?
Topics: Aminoquinolines; Animals; Antimalarials; Drug Evaluation, Preclinical; Ether-A-Go-Go Potassium Channels; Hemin; Hepatocytes; Humans; In Vitro Techniques; Liver; Mice; Microsomes, Liver; Parasite Load; Plasmodium berghei; Plasmodium falciparum; Structure-Activity Relationship; Tetraoxanes | 2016 |
Antimalarial Pyrido[1,2-a]benzimidazoles: Lead Optimization, Parasite Life Cycle Stage Profile, Mechanistic Evaluation, Killing Kinetics, and in Vivo Oral Efficacy in a Mouse Model.
Topics: Animals; Antimalarials; Benzimidazoles; Life Cycle Stages; Malaria; Male; Mice; Plasmodium berghei; Structure-Activity Relationship | 2017 |
Design and Synthesis of Orally Bioavailable Piperazine Substituted 4(1H)-Quinolones with Potent Antimalarial Activity: Structure-Activity and Structure-Property Relationship Studies.
Topics: Animals; Antimalarials; Drug Design; Humans; Mice; Piperazine; Plasmodium falciparum; Quinolones; Solubility; Structure-Activity Relationship | 2018 |
Discovery and Structural Optimization of Acridones as Broad-Spectrum Antimalarials.
Topics: Acridones; Animals; Antimalarials; Disease Models, Animal; Drug Discovery; Hep G2 Cells; Humans; Malaria; Mice; Plasmodium; Species Specificity; Structure-Activity Relationship | 2019 |
Molecular Design and Synthesis of Ivermectin Hybrids Targeting Hepatic and Erythrocytic Stages of
Topics: Animals; Anopheles; Antimalarials; Binding Sites; Chloride Channels; Drug Design; Insecticides; Ivermectin; Molecular Docking Simulation; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium berghei; Plasmodium falciparum; Protein Binding; Structure-Activity Relationship | 2020 |
Lead Optimization of Second-Generation Acridones as Broad-Spectrum Antimalarials.
Topics: Acridones; Administration, Oral; Animals; Antimalarials; Cell Survival; Disease Models, Animal; Female; Half-Life; Hep G2 Cells; Humans; Life Cycle Stages; Malaria; Male; Mice; Mice, Inbred C57BL; Plasmodium falciparum; Structure-Activity Relationship | 2020 |
Drugs for AIDS and associated infections.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Antiprotozoal Agents; Antiviral Agents; Atovaquone; Candidiasis, Oral; Clindamycin; Clotrimazole; Cryptosporidiosis; Cytomegalovirus Infections; Dapsone; Didanosine; Drug Combinations; Drug Therapy, Combination; Fluconazole; Flucytosine; Folic Acid Antagonists; Foscarnet; Glucuronates; Herpes Simplex; Herpes Zoster; Humans; Isoniazid; Itraconazole; Ketoconazole; Lamivudine; Mycobacterium avium-intracellulare Infection; Naphthoquinones; Nystatin; Pentamidine; Pneumocystis Infections; Pneumonia, Pneumocystis; Prednisone; Primaquine; Reverse Transcriptase Inhibitors; Stavudine; Syphilis; Toxoplasmosis; Trimetrexate; Tuberculosis; Zalcitabine; Zidovudine | 1995 |
Adverse effects of antimalarial prophylactic drugs: an important consideration in the risk-benefit equation.
Topics: Animals; Anti-Bacterial Agents; Antimalarials; Atovaquone; Azithromycin; Chloroquine; Drug Therapy, Combination; Humans; Malaria; Mefloquine; Naphthoquinones; Plasmodium falciparum; Plasmodium vivax; Primaquine; Proguanil; Pyrimethamine; Risk Assessment | 1998 |
Toxicity related to chloroquine treatment of resistant vivax malaria.
Topics: Adult; Animals; Antimalarials; Atovaquone; Chloroquine; Drug Overdose; Humans; Malaria, Vivax; Male; Naphthoquinones; Plasmodium vivax; Primaquine; Proguanil | 2003 |
Prophylactic use of antimalarials during pregnancy.
Topics: Antimalarials; Atovaquone; Chemoprevention; Chloroquine; Doxycycline; Drug Combinations; Female; Humans; Hydroxychloroquine; Malaria; Mefloquine; Pregnancy; Pregnancy Complications, Parasitic; Primaquine; Proguanil; Travel | 2011 |
Focused Screening and Treatment (FSAT): a PCR-based strategy to detect malaria parasite carriers and contain drug resistant P. falciparum, Pailin, Cambodia.
Topics: Artemisinins; Atovaquone; Base Sequence; Cambodia; Carrier State; Cross-Sectional Studies; Demography; Drug Combinations; Drug Resistance; Humans; Interviews as Topic; Malaria, Falciparum; Mass Screening; Molecular Sequence Data; Plasmodium falciparum; Polymerase Chain Reaction; Prevalence; Primaquine; Proguanil; Sequence Analysis, DNA; Statistics, Nonparametric | 2012 |
Transgenic fluorescent Plasmodium cynomolgi liver stages enable live imaging and purification of Malaria hypnozoite-forms.
Topics: Animals; Animals, Genetically Modified; Antimalarials; Atovaquone; Fluorescence; Humans; Liver; Plasmodium cynomolgi; Primaquine | 2013 |
Causal prophylactic efficacy of primaquine, tafenoquine, and atovaquone-proguanil against Plasmodium cynomolgi in a rhesus monkey model.
Topics: Aminoquinolines; Animals; Antimalarials; Atovaquone; Disease Models, Animal; Drug Combinations; Macaca mulatta; Malaria; Parasitemia; Plasmodium cynomolgi; Primaquine; Proguanil | 2014 |
Imported malaria is stable from Africa but declining from Asia.
Topics: Adolescent; Adult; Africa; Aged; Antimalarials; Asia; Atovaquone; Chemoprevention; Child; Child, Preschool; Chloroquine; Delayed Diagnosis; Denmark; Drug Combinations; Female; Humans; Incidence; Infant; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; Middle Aged; Primaquine; Proguanil; Recurrence; Risk Factors; Severity of Illness Index; Travel; Young Adult | 2014 |
Assessment of real-time method to detect liver parasite burden under different experimental conditions in mice infected with Plasmodium yoelii sporozoites.
Topics: Animals; Antimalarials; Atovaquone; Liver; Malaria; Mice; Parasite Load; Plasmodium yoelii; Primaquine; Real-Time Polymerase Chain Reaction; Sporozoites; Treatment Outcome | 2015 |
Misdiagnosis of Babesiosis as Malaria, Equatorial Guinea, 2014.
Topics: Adult; Antiprotozoal Agents; Artemisinins; Atovaquone; Azithromycin; Babesia microti; Babesiosis; Diagnostic Errors; Drug Combinations; Equatorial Guinea; Female; Humans; Malaria; Primaquine; Proguanil; Spain; Travel | 2018 |
Diagnosis of malaria in a traveler 9 months after returning from West Africa by
Topics: Africa, Western; Antimalarials; Atovaquone; Drug Combinations; Germany; Humans; Malaria; Male; Middle Aged; Molecular Diagnostic Techniques; Nucleic Acid Amplification Techniques; Plasmodium ovale; Primaquine; Proguanil; Sensitivity and Specificity; Travel-Related Illness | 2019 |
Deployment and Travel Medicine Knowledge, Attitudes, Practices, and Outcomes Study (KAPOS): Malaria Chemoprophylaxis Prescription Patterns in the Military Health System.
Topics: Adolescent; Adult; Aged; Antimalarials; Atovaquone; Chemoprevention; Chloroquine; Doxycycline; Drug Combinations; Female; Humans; Malaria; Male; Mefloquine; Middle Aged; Military Medicine; Military Personnel; Practice Patterns, Physicians'; Primaquine; Proguanil; United States; Young Adult | 2020 |
Atovaquone, chloroquine, primaquine, quinine and tetracycline: antiproliferative effects of relevant antimalarials on Neospora caninum.
Topics: Antimalarials; Atovaquone; Chloroquine; Neospora; Primaquine; Quinine; Tetracyclines | 2021 |